Innovations for Next-Generation Antibody-Drug Conjugates - Cancer Drug Discovery and Development - - Books - Springer Nature Switzerland AG - 9783030086275 - February 8, 2019
In case cover and title do not match, the title is correct

Innovations for Next-Generation Antibody-Drug Conjugates - Cancer Drug Discovery and Development Softcover Reprint of the Original 1st 2018 edition

Price
$ 157.99
excl. VAT

Ordered from remote warehouse

Expected to be ready for shipping Jun 30 - Jul 6

Our customers say:

14-day return policy in accordance with European consumer protection law
Top ranking on Trustpilot
Add to your iMusic wish list

Also available as:

While the book primarily addresses ADCs for solid tumors, the last chapter explores the emerging interest in using ADCs to treat other diseases. The therapeutic rationale of ADCs is strong: to direct small molecules to the desired site of action (and away from normal tissues) by conjugation to antibodies or other targeting moieties.

357 pages, 52 Illustrations, color; 18 Illustrations, black and white; VIII, 357 p. 70 illus., 52 il

Media Books     Paperback Book   (Book with soft cover and glued back)
Released February 8, 2019
ISBN13 9783030086275
Publishers Springer Nature Switzerland AG
Pages 357
Dimensions 150 × 220 × 10 mm   ·   512 g
Language German  
Editor Damelin, Marc

Mere med samme udgiver